Review



vitro div 4  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress vitro div 4
    Vitro Div 4, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vitro+div+4/LDN-193189/pm42037491-257-9-20
    Average 94 stars, based on 11 article reviews
    vitro div 4 - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Inhibition:

    Article Title: Iloperidone treatment mitigates the Juvenile Huntington's Disease phenotype possibly via Sigma-1 Receptor Modulation.
    Article Snippet: .. Briefly, dual-smad inhibition was started at day of in vitro (DIV) 4 using 500 nM LDN193189 and 10 μM SB431542 (MedChemexpress, Monmouth Junction, NJ, USA) till DIV 18. .. The cortical neurons’ maturation proceeded from DIV30 to DIV70 in 1 : 1 DMEM-F12 containing 1% N2 and 2% B27 supplements (Thermo Fisher Scientific).

    In Vitro:

    Article Title: Iloperidone treatment mitigates the Juvenile Huntington's Disease phenotype possibly via Sigma-1 Receptor Modulation.
    Article Snippet: .. Briefly, dual-smad inhibition was started at day of in vitro (DIV) 4 using 500 nM LDN193189 and 10 μM SB431542 (MedChemexpress, Monmouth Junction, NJ, USA) till DIV 18. .. The cortical neurons’ maturation proceeded from DIV30 to DIV70 in 1 : 1 DMEM-F12 containing 1% N2 and 2% B27 supplements (Thermo Fisher Scientific).



    Similar Products

    94
    MedChemExpress vitro div 4
    Vitro Div 4, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vitro+div+4/LDN-193189/pm42037491-257-9-20
    Average 94 stars, based on 1 article reviews
    vitro div 4 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Addgene inc vitro div 4
    (a) Experimental design. Schematic of the imaging configuration. Whole-cell voltage-clamp recordings were used to evoke action potentials (APs) in <t>SF-iGluSnFR-transfected</t> pyramidal neurons while monitoring glutamate release from their axonal boutons. (b) Identification of active boutons. Image analysis from an axonal fragment of a representative wild type (WT) neuron. Top: stimulation paradigm showing the consecutive paired-pulse (20 Hz) and train (50 APs at 20 Hz) protocols. Example raw fluorescence images acquired after AP stimulation during paired-pulse trials and the train. Bottom: corresponding images after application of a spatiotemporal filter, illustrating vesicular release successes and failures in active boutons within the selected region of interest. Bottom right: maximal projection of the filtered stack, visualising all boutons that released at least one vesicle during the stimulation protocol (five active boutons in this example). (c) Automatic event detection. Top: raw fluorescence trace from an example bouton (b1, WT) indicated by an arrowhead in (b). Bottom: corresponding deconvolved trace showing detected quantal release events. Vertical dotted lines mark AP timings; gaps between traces correspond to 10 s intersweep intervals. Events were identified as local maxima exceeding the detection threshold θ (horizontal dashed line), defined as 4 standard deviations (σ) of baseline fluorescence noise (see Methods). Blue and red circles denote synchronous and asynchronous events (<10 ms and >10 ms after the preceding AP, respectively). (d) Quantal analysis. Amplitudes of all detected events (top raster) were used to generate a quasi-continuous amplitude distribution by bootstrap resampling with bouton specific noise, which improved convergence and stability of the Gaussian mixture fit (see Methods). The resulting distribution was fitted with a sum of Gaussian functions to estimate the quantal amplitude (q, green line on the deconvolved traces in (c)), corresponding to the mean single vesicle SF iGluSnFR response. Peaks at q and 2q indicate one and two vesicle release events, respectively. See additional examples in and . (e) Functional bouton parameters for the example bouton b1 (WT). n T , n S , and n A represent total, synchronous, and asynchronous release efficacies (average number of quanta released per action potential); n A / n T denotes the asynchronous release fraction, and FDI is Facilitation-Depression Index. Parameters were calculated for the 1 st (AP1) and 2 nd (AP2) stimuli of the paired-pulse protocol and for the steady-state phase of the train (Train; APs 11– 50). See Methods for exact definitions.
    Vitro Div 4, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vitro+div+4/pAAV%2EhSynapsin%2ESF-iGluSnFR%2EA184S+(Plasmid+%23106174)/bio_rxiv__64898__2025__12__19__695358-202-8-14
    Average 93 stars, based on 1 article reviews
    vitro div 4 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    96
    steraloids inc vitro div
    (a) Experimental design. Schematic of the imaging configuration. Whole-cell voltage-clamp recordings were used to evoke action potentials (APs) in <t>SF-iGluSnFR-transfected</t> pyramidal neurons while monitoring glutamate release from their axonal boutons. (b) Identification of active boutons. Image analysis from an axonal fragment of a representative wild type (WT) neuron. Top: stimulation paradigm showing the consecutive paired-pulse (20 Hz) and train (50 APs at 20 Hz) protocols. Example raw fluorescence images acquired after AP stimulation during paired-pulse trials and the train. Bottom: corresponding images after application of a spatiotemporal filter, illustrating vesicular release successes and failures in active boutons within the selected region of interest. Bottom right: maximal projection of the filtered stack, visualising all boutons that released at least one vesicle during the stimulation protocol (five active boutons in this example). (c) Automatic event detection. Top: raw fluorescence trace from an example bouton (b1, WT) indicated by an arrowhead in (b). Bottom: corresponding deconvolved trace showing detected quantal release events. Vertical dotted lines mark AP timings; gaps between traces correspond to 10 s intersweep intervals. Events were identified as local maxima exceeding the detection threshold θ (horizontal dashed line), defined as 4 standard deviations (σ) of baseline fluorescence noise (see Methods). Blue and red circles denote synchronous and asynchronous events (<10 ms and >10 ms after the preceding AP, respectively). (d) Quantal analysis. Amplitudes of all detected events (top raster) were used to generate a quasi-continuous amplitude distribution by bootstrap resampling with bouton specific noise, which improved convergence and stability of the Gaussian mixture fit (see Methods). The resulting distribution was fitted with a sum of Gaussian functions to estimate the quantal amplitude (q, green line on the deconvolved traces in (c)), corresponding to the mean single vesicle SF iGluSnFR response. Peaks at q and 2q indicate one and two vesicle release events, respectively. See additional examples in and . (e) Functional bouton parameters for the example bouton b1 (WT). n T , n S , and n A represent total, synchronous, and asynchronous release efficacies (average number of quanta released per action potential); n A / n T denotes the asynchronous release fraction, and FDI is Facilitation-Depression Index. Parameters were calculated for the 1 st (AP1) and 2 nd (AP2) stimuli of the paired-pulse protocol and for the steady-state phase of the train (Train; APs 11– 50). See Methods for exact definitions.
    Vitro Div, supplied by steraloids inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vitro+div+4/4-ANDROSTEN-17%CE%B2-OL-3-ONE/pmc04460015-47-10-30
    Average 96 stars, based on 1 article reviews
    vitro div - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    Image Search Results


    (a) Experimental design. Schematic of the imaging configuration. Whole-cell voltage-clamp recordings were used to evoke action potentials (APs) in SF-iGluSnFR-transfected pyramidal neurons while monitoring glutamate release from their axonal boutons. (b) Identification of active boutons. Image analysis from an axonal fragment of a representative wild type (WT) neuron. Top: stimulation paradigm showing the consecutive paired-pulse (20 Hz) and train (50 APs at 20 Hz) protocols. Example raw fluorescence images acquired after AP stimulation during paired-pulse trials and the train. Bottom: corresponding images after application of a spatiotemporal filter, illustrating vesicular release successes and failures in active boutons within the selected region of interest. Bottom right: maximal projection of the filtered stack, visualising all boutons that released at least one vesicle during the stimulation protocol (five active boutons in this example). (c) Automatic event detection. Top: raw fluorescence trace from an example bouton (b1, WT) indicated by an arrowhead in (b). Bottom: corresponding deconvolved trace showing detected quantal release events. Vertical dotted lines mark AP timings; gaps between traces correspond to 10 s intersweep intervals. Events were identified as local maxima exceeding the detection threshold θ (horizontal dashed line), defined as 4 standard deviations (σ) of baseline fluorescence noise (see Methods). Blue and red circles denote synchronous and asynchronous events (<10 ms and >10 ms after the preceding AP, respectively). (d) Quantal analysis. Amplitudes of all detected events (top raster) were used to generate a quasi-continuous amplitude distribution by bootstrap resampling with bouton specific noise, which improved convergence and stability of the Gaussian mixture fit (see Methods). The resulting distribution was fitted with a sum of Gaussian functions to estimate the quantal amplitude (q, green line on the deconvolved traces in (c)), corresponding to the mean single vesicle SF iGluSnFR response. Peaks at q and 2q indicate one and two vesicle release events, respectively. See additional examples in and . (e) Functional bouton parameters for the example bouton b1 (WT). n T , n S , and n A represent total, synchronous, and asynchronous release efficacies (average number of quanta released per action potential); n A / n T denotes the asynchronous release fraction, and FDI is Facilitation-Depression Index. Parameters were calculated for the 1 st (AP1) and 2 nd (AP2) stimuli of the paired-pulse protocol and for the steady-state phase of the train (Train; APs 11– 50). See Methods for exact definitions.

    Journal: bioRxiv

    Article Title: Synaptotagmin-7 is required for synchronous but not asynchronous facilitation of glutamate release at cortical boutons

    doi: 10.64898/2025.12.19.695358

    Figure Lengend Snippet: (a) Experimental design. Schematic of the imaging configuration. Whole-cell voltage-clamp recordings were used to evoke action potentials (APs) in SF-iGluSnFR-transfected pyramidal neurons while monitoring glutamate release from their axonal boutons. (b) Identification of active boutons. Image analysis from an axonal fragment of a representative wild type (WT) neuron. Top: stimulation paradigm showing the consecutive paired-pulse (20 Hz) and train (50 APs at 20 Hz) protocols. Example raw fluorescence images acquired after AP stimulation during paired-pulse trials and the train. Bottom: corresponding images after application of a spatiotemporal filter, illustrating vesicular release successes and failures in active boutons within the selected region of interest. Bottom right: maximal projection of the filtered stack, visualising all boutons that released at least one vesicle during the stimulation protocol (five active boutons in this example). (c) Automatic event detection. Top: raw fluorescence trace from an example bouton (b1, WT) indicated by an arrowhead in (b). Bottom: corresponding deconvolved trace showing detected quantal release events. Vertical dotted lines mark AP timings; gaps between traces correspond to 10 s intersweep intervals. Events were identified as local maxima exceeding the detection threshold θ (horizontal dashed line), defined as 4 standard deviations (σ) of baseline fluorescence noise (see Methods). Blue and red circles denote synchronous and asynchronous events (<10 ms and >10 ms after the preceding AP, respectively). (d) Quantal analysis. Amplitudes of all detected events (top raster) were used to generate a quasi-continuous amplitude distribution by bootstrap resampling with bouton specific noise, which improved convergence and stability of the Gaussian mixture fit (see Methods). The resulting distribution was fitted with a sum of Gaussian functions to estimate the quantal amplitude (q, green line on the deconvolved traces in (c)), corresponding to the mean single vesicle SF iGluSnFR response. Peaks at q and 2q indicate one and two vesicle release events, respectively. See additional examples in and . (e) Functional bouton parameters for the example bouton b1 (WT). n T , n S , and n A represent total, synchronous, and asynchronous release efficacies (average number of quanta released per action potential); n A / n T denotes the asynchronous release fraction, and FDI is Facilitation-Depression Index. Parameters were calculated for the 1 st (AP1) and 2 nd (AP2) stimuli of the paired-pulse protocol and for the steady-state phase of the train (Train; APs 11– 50). See Methods for exact definitions.

    Article Snippet: At 4-6 days in vitro (DIV 4-6), neurons were transfected with the plasmid pAAV.hSynap.SF-iGluSnFR.A184V (Addgene #106174; ( )) using Neuromag reagent (OZ Biosciences).

    Techniques: Imaging, Transfection, Fluorescence, Functional Assay